Intestinourinary Fistulas
RYAN L. MORI
ERIC A. KLEIN
KENNETH W. ANGERMEIER
An intestinourinary fistula is a pathologic extra-anatomic epithelialized connection that can be described based on the respective intestinal and urologic segments involved (i.e., enterovesical, colovesical, rectovesical, rectourethral). This chapter will describe the etiology, evaluation, and management of intestinourinary fistulas with special emphasis on intestinovesical and rectourethral fistulas.
INTESTINOVESICAL FISTULAS
Etiology
The etiology of enterovesical and colovesical fistulas can be divided into three broad categories: inflammatory, neoplastic, and traumatic (Table 25.1). In modern series, diverticular disease is the most common etiology representing 67% of cases, followed by malignancy in 15% and Crohn disease in 9% (1,2). A history of pelvic irradiation increases susceptibility and complexity. Men are affected twice as commonly as women due to the presence of the uterus and broad ligament as a protective barrier. Up to 50% of women with colovesical fistulas have undergone previous hysterectomy (3).
Diagnosis
Although the inciting pathology is usually intestinal, the presenting symptoms are often urinary in nature. The most common presenting complaints are pneumaturia reported in 57% to 91% and fecaluria in 42% to 76%. Recurrent urinary tract infections, irritative voiding symptoms, and abdominal pain are also common, whereas passage of urine per rectum is not
typical (1,2,3,4). Physical signs suggestive of enterovesical fistulas are often subtle or absent but may include a palpable mass or abdominal tenderness with or without local peritonitis. Associated physical findings are more commonly associated with fistulas secondary to inflammatory bowel disease (5). In patients with rectal disease, a rectal abnormality or tenderness may be present. Urinalysis usually reveals pyuria with or without hematuria, and urine cultures are positive in the majority of patients with the most common growth patterns being multiple organisms or isolated Escherichia coli (2).
typical (1,2,3,4). Physical signs suggestive of enterovesical fistulas are often subtle or absent but may include a palpable mass or abdominal tenderness with or without local peritonitis. Associated physical findings are more commonly associated with fistulas secondary to inflammatory bowel disease (5). In patients with rectal disease, a rectal abnormality or tenderness may be present. Urinalysis usually reveals pyuria with or without hematuria, and urine cultures are positive in the majority of patients with the most common growth patterns being multiple organisms or isolated Escherichia coli (2).
TABLE 25.1 SPECIFIC CAUSES OF VESICOENTERIC FISTULAS | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Given the symptomatic nature of enterovesical and colovesical fistulas, the diagnosis is typically a clinical one. The goal of assessment is not only to diagnose and localize the fistula but also to identify and develop a treatment strategy for the underlying intestinal or urinary pathology. Radiographic assessment is used as an adjunct and may assist with anatomic localization and surgical planning. Traditionally, barium enema has been used as a first study, but more recent series have demonstrated fistula identification rates of only 20% to 42% (1,2,3,4). Other imaging modalities including computerized tomography (CT) and magnetic resonance imaging (MRI) have mixed results in the literature in terms of diagnosis. However, although axial imaging may fail to demonstrate the fistula, it may aid in surgical planning and identification of etiology and may be diagnostic based on the associated indirect findings of the fistula including air in the bladder or focal bladder or bowel wall thickening. In our institution, the use of CT cystography has replaced other anatomic and functional studies including standard cystography, CT urogram, and MRI.
Functional studies have been described for the diagnosis of enterovesical fistula and include the charcoal test, urinary or rectal visualization of administered dyes, the poppy seed test in which the urine is evaluated for orally consumed poppy seeds, or the Bourne test where urine is examined for barium following a nondiagnostic barium enema. Although the sensitivities of these tests may approach 100% in the literature (4), they are seldom performed because they often fail to provide anatomic detail and the diagnosis of fistula is usually self-evident based on the clinical picture.
Direct visualization with colonoscopy and cystoscopy is a key component of the analysis. Colonoscopy rarely identifies a fistula tract but is recommended for its importance in evaluating the etiology and extent of the intestinal disease (1,2,3,4). Cystoscopy is the most common abnormal investigation. Although fistula identification rates are reported to be from 10% to 60% (1,3), up to 90% of cystoscopies may show indirect evidence of the fistula including bullous edema or inflammatory bladder wall abnormalities (2).
Management
Given the symptomatic nature, the potential for morbidity, and the associated underlying bowel pathology, most intestinovesical fistulas should be addressed surgically. The principles of surgical management include removal of the diseased segment of intestine as well as the fistula tract with or without defunctionalization of the affected bowel segment with a proximal diversion. Typically, the bladder can be managed with 7 to 10 days of catheter drainage with minimal need for resection or repair especially in the setting of benign bowel disease (6). Larger bladder injuries are typically managed with two-layered closures. For this reason, surgery is often directed by the colorectal surgeon with assistance from the urologist when necessary.
A one-stage approach with bowel resection and reanastomosis has become the standard because it is associated with fewer complications and lower mortality, but management must be based on the underlying pathology on a case-by-case basis. Even in the setting of abscess or purulent peritonitis, a one-stage approach can still be safely performed given that the inflammatory focus is resectable and the bowel anastomosis can be “quarantined from any inflammatory nest” (3). A two-stage approach should be considered in patients with bowel obstruction or when there is concern for a healthy anastomosis such as in the setting of extensive locoregional abdominal sepsis, significant inflammation, or in the setting of prior radiation. The two stages may consist of bowel resection with a Hartmann procedure followed by reanastomosis, or resection with anastomosis and proximal diversion followed by delayed restoration of bowel continuity. Some patients, especially those with a history of radiation, may require permanent bowel and/or bladder diversion.
Nonoperative or minimally invasive management may be considered in patients who are deemed unfit for surgery. Spontaneous closure is rare but may occur especially in the setting of traumatic rather than inflammatory fistulas. Evaluation of several series of patients with intestinovesical fistula provides some information on patients who refuse or are unfit for surgery. Although Amin et al. (7) demonstrate that patients with diverticular colovesical fistulas may get by without significant complications in some circumstances, Thomas et al. (1) demonstrate a high rate of mortality without intervention.
Surgical Technique
One-Stage Surgery
On the day prior to surgery, a mechanical bowel preparation is administered and the patient is maintained on a clear liquid diet. Gram-negative and anaerobic coverage is provided by administering a third-generation cephalosporin and metronidazole within 1 hour of surgical incision.
The majority of fistulas can be best approached by a midline laparotomy incision extending from the pubic ramus to the umbilicus (Fig. 25.1), with cranial extension as needed. The peritoneum is entered, adhesiolysis is performed as needed, and the site of the fistula is identified. The remainder of the procedure is determined by the underlying disease causing the fistula and any associated complications. Patients with Crohn disease often have multifocal fistulas not involving the urinary tract and may require multiple resections or stricturoplasties. In malignant fistulas, the requisite oncologic procedure is performed with resection of the fistula tract.
Fistulas associated with malignancy or large cystotomies may require partial cystectomy. Closure of small or unidentified cystotomies is not essential. Larger bladder defects should be closed in two layers with absorbable suture. A large or difficult to access bladder defect may require a midline anterior cystotomy. In the setting of ureteral involvement, ureteroneocystostomy may be required. Whenever possible, healthy tissue such as an omental or peritoneal flap should be interposed between the bowel and the bladder repairs, especially in the setting of radiation or poor tissue quality. Extraperitoneal
drainage should be conducted, especially in the setting of a large bladder repair. A urethral catheter should be maintained for at least 7 days postoperatively, and in the setting of a more involved bladder repair, suprapubic catheter drainage may be used as well. A laparoscopic approach has also been described with good success (8).
drainage should be conducted, especially in the setting of a large bladder repair. A urethral catheter should be maintained for at least 7 days postoperatively, and in the setting of a more involved bladder repair, suprapubic catheter drainage may be used as well. A laparoscopic approach has also been described with good success (8).
Outcomes
The overall complication rate from intestinovesical fistula surgery has been reported to range between 6.4% and 49% (1). Major complications of the surgical management of intestinovesical fistula include death (0% to 3.5%), cardiopulmonary event (1.3% to 6.7%), deep venous thrombosis (0% to 1.2%), anastomotic leak (1.1% to 5.3%), prolonged ileus (0% to 4.8%), enterocutaneous fistula (0% to 1.2%), and wound infection (10% to 20%). Fistulas secondary to radiation and malignancy are associated with greater morbidity (9,10,11).
The results of the one-stage procedure for enterovesical fistula are dependent on the etiology of the fistula. The fistula recurrence rate in the setting of diverticular disease is virtually nonexistent (1,3). However, fistula recurrence in the setting of Crohn’s disease or malignancy can occur in up to 13% and 15% of patients, respectively (9,12). Urinary leak rates are very low but have approached 8% in small series (12) of fistulas in Crohn patients.
RECTOURETHRAL FISTULAS
Background
Over the past decade, there have been some changes in the surgical approach to rectourethral fistulas (RUFs). This has corresponded with a number of new therapies for prostate cancer and the transition of management toward the urologic surgeon. There are several surgical approaches that are acceptable. The management of each case is unique and must consider fistula etiology, complexity, associated urinary or bowel dysfunction, associated urethral or bladder neck stricture, and patient performance status.
The urologic surgeon should be familiar with the transperineal approach because it offers excellent exposure to both the urinary and rectal components of the fistula, allows for multiple potential interposition flaps, and is applicable to the repair of both simple and complex fistulas.